Biomarkers predict long-term outcomes in juvenile idiopathic arthritis
Different mechanisms of response could explain poor treatment response in rheumatoid factor positive patients Data demonstrate the possibility of using biomarkers (developed from whole blood gene expression profiles) in children with juvenile idiopathic arthritis (JIA) to predict the status of their disease at 12 months. The long-term disease status at 12 months was accurately predicted […]
